News Sentiment

CBIO sentiment intelligence

Crescent Biopharma, Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 52 Balanced news tone 57 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 14.75 Week of 17 Jul 2026
Weighted tone 52/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

87/100 classification confidence.

Company focus 48

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend active

-14.9% over one week, -16.6% over four weeks, trend active, and near fair-value range.

Latest direct headline Positive

Fairmount Funds holds 16.5% of Crescent Biopharma (CBIO) after July 2026 deal

Market Reaction

Price moving ahead of tone

63/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 87/100 classification
One-week reaction -14.9% Price reacting lower
Trend fit Trend active -16.6% over four weeks
Fair value 1.6% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 11
Neutral 39
Negative 7

Relevance

Why the article matched

Direct first
Direct company coverage 48
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 14
GlobeNewswire 7
Market source 6
TradingView 6
Quartr 3
Moomoo 3
Quiver Quantitative 3
MT Newswires 2

Event Lens

What the news is about

Classified themes
Market update 42
Earnings 12
Deals and strategy 2
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-57 of 57
MSN Direct company coverage

Crescent Biopharma Inc (CBIO) Stock, Price, News, Quotes, Forecast and Insights | MSN Money

This article provides stock information for Crescent Biopharma Inc (CBIO), including its current price, daily and 52-week ranges, open price, and previous close. It also lists key financial metrics such as market capitalization, shares outstanding, and EPS, indicating the stock i

Tone
Positive 63/100
Event
Earnings
Published
11 Jul 2026 13:40
Source
MSN
TradingView Direct company coverage

Price to sales forward of Crescent Biopharma, Inc. – NASDAQ:CBIO

This article provides the "Price to sales forward" financial metric for Crescent Biopharma, Inc. (NASDAQ: CBIO). The content appears to be a stub or a section from a financial data platform, indicating the value and change of this specific financial ratio for the company. While t

Tone
Neutral 50/100
Event
Market update
Published
07 Jul 2026 12:40
Source
TradingView
TradingView Direct company coverage

Enterprise value to EBITDA forward of Crescent Biopharma, Inc. – NASDAQ:CBIO

The article provides the enterprise value to EBITDA forward for Crescent Biopharma, Inc. (NASDAQ: CBIO) as presented on TradingView. It highlights that this financial metric and related data are sourced from ICE Data Services and FactSet, with SEC filings provided by Quartr. The

Tone
Neutral 50/100
Event
Market update
Published
07 Jul 2026 04:11
Source
TradingView
TradingView Direct company coverage

Price to book forward of Crescent Biopharma, Inc. – NASDAQ:CBIO

The article discusses the "Price to book forward" metric for Crescent Biopharma, Inc. (NASDAQ: CBIO) as presented on TradingView. It appears to be a financial data point without further analysis or context within the provided snippet. The content primarily lists navigation and fo

Tone
Neutral 50/100
Event
Market update
Published
06 Jul 2026 16:11
Source
TradingView